Sexual dimorphism in hepatic PPAR alpha and CYP4a12a expression is associated with reduced development of drug-induced non-alcoholic steatohepatitis in female IL-33−/− mice. The gene discussed is IL33; the disease is metabolic dysfunction-associated steatohepatitis.